AEON Biopharma Inc (AEON)
1.52
+0.02
(+1.33%)
USD |
NYAM |
May 17, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
AEON Biopharma Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 125.14M |
| May 16, 2024 | 124.50M |
| May 15, 2024 | 126.21M |
| May 14, 2024 | 127.28M |
| May 13, 2024 | 128.35M |
| May 10, 2024 | 129.43M |
| May 09, 2024 | 127.93M |
| May 08, 2024 | 130.28M |
| May 07, 2024 | 126.43M |
| May 06, 2024 | 127.28M |
| May 03, 2024 | 128.78M |
| May 02, 2024 | 164.35M |
| May 01, 2024 | 168.85M |
| April 30, 2024 | 174.85M |
| April 29, 2024 | 177.85M |
| April 26, 2024 | 200.99M |
| April 25, 2024 | 183.42M |
| April 24, 2024 | 178.28M |
| April 23, 2024 | 184.49M |
| April 22, 2024 | 193.49M |
| April 19, 2024 | 192.21M |
| April 18, 2024 | 232.49M |
| April 17, 2024 | 237.85M |
| April 16, 2024 | 239.99M |
| April 15, 2024 | 244.49M |
| Date | Value |
|---|---|
| April 12, 2024 | 255.20M |
| April 11, 2024 | 274.70M |
| April 10, 2024 | 274.70M |
| April 09, 2024 | 261.63M |
| April 08, 2024 | 275.56M |
| April 05, 2024 | 272.34M |
| April 04, 2024 | 268.92M |
| April 03, 2024 | 265.70M |
| April 02, 2024 | 257.77M |
| April 01, 2024 | 251.56M |
| March 28, 2024 | 340.91M |
| March 27, 2024 | 353.34M |
| March 26, 2024 | 336.84M |
| March 25, 2024 | 344.77M |
| March 22, 2024 | 337.48M |
| March 21, 2024 | 325.91M |
| March 20, 2024 | 362.12M |
| March 19, 2024 | 400.91M |
| March 18, 2024 | 441.40M |
| March 15, 2024 | 429.83M |
| March 14, 2024 | 403.05M |
| March 13, 2024 | 364.27M |
| March 12, 2024 | 358.05M |
| March 11, 2024 | 350.55M |
| March 08, 2024 | 333.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
124.50M
Minimum
May 16 2024
441.40M
Maximum
Mar 18 2024
284.70M
Average
307.48M
Median
Mar 11 2022
Enterprise Value Benchmarks
| Amgen Inc | 221.93B |
| Gilead Sciences Inc | 104.76B |
| Pulse Biosciences Inc | 396.42M |
| Amneal Pharmaceuticals Inc | 4.738B |
| Xilio Therapeutics Inc | 8.100M |